Stock tips for March 14, 2013

Commentary

oi-Sneha

By Sneha B K

Published: Thursday, March 14, 2013, 9:12 [IST]

Here are a few stock ideas from leading brokerage houses in the country.

Ipca Laboratories:

Dolat Capital is bullish on Ipca Laboratories and has recommended accumulate rating on the stock with a target price of Rs 572 in its March 11, 2013 research report.

"Ipca Laboratories has transformed itself from a leading API manufacturer to a fully integrated formulation company. We anticipate growth in its domestic franchise (16% CAGR over FY13-15E) to be mainly driven by key TA's - CVS & pain management. Notably, approx. 45-50% of the company's current product portfolio will come under coverage of the new pricing policy, which may restrict growth momentum.

Bajaj Hindusthan:

VK Sharma, Head Private Broking & Wealth Management, HDFC Securities is of the view that one should sell Bajaj Hindusthan .

Sharma told CNBC-TV18, "The prospects of the industry would change after you have whatever those steps, which are required when levy sugar goes and partial decontrol happens. The sector would look up but I would advise that this sugar sector is a very small sector in the overall economy. My sense is that already a lot of people are buying these stocks in anticipation of those events happening. So, essentially when you are invested in Bajaj Hindusthan, it is less of a sugar company and more of a power company."

NMDC:

Angel Broking is bullish on NMDC and has recommended buy rating on the stock with a target price of Rs 178 in its March 13, 2013 research report.

"NMDC's 3QFY2013 sales volumes were below our and street expectations. Lower volumes during 3QFY2013 are attributable to lower demand for NMDC's customers' products. While sponge iron and domestic steel prices declined during 3QFY2013, NMDC did not take price cuts, as global iron ore prices had increased ~50% during August-December 2012. Hence, higher ore prices resulted in lower demand, especially for lumps, from secondary steel producers. NMDC, as a result, announced two price cuts ie a 6% cut followed by a 2.2% cut during 4QFY2013, while it retained prices of fines a move that would restore its volume growth in our view.

Zee Entertainment:

Way2Wealth is bullish on Zee Entertainment Enterprises (ZEEL) and has recommended accumulate rating on the stock with a target price of Rs 250 in its March 13, 2013 research report.

"According to the recent Government data, Set-Top Box seeding is completed in Mumbai and Delhi; MSOs and LCOs are currently in the process of implementing backbone structure to build accurate subscriber counting mechanism to aid subscriber specific revenue sharing between stakeholders. But, some hiccups related to implementation still left into the system.

GoodReturns.in

DISCLAIMER: GoodReturns provides you with information covering shares, futures and options based on broker's reports as stated on various media. Investors are, however, warned that they should NOT take any buy or sell decision based on these views expressed in the article. Investors should consult their own financial and share advisors before taking purchase or sale decisions. GoodReturns does not take any responsibility for any losses incurred by investors who take their cues from the above article.